The European Medicines Agency (EMA) suggested to the vaccinated people with the biological of AstraZeneca monitoring your health status for two weeks after receiving the doses, after it was confirmed that the thrombus episodes, unleashed in some patients, developed as a side effect of treatment from the Cambridge, UK-based pharmaceutical company.
Although the representatives of the drug agency assured that the cases in which the inoculated personas suffered a b, as a result of the formation of a clot in one of the five blood vessels, were “very rare”, classifying them as a “rare side effect”, they called on the population immunized with the AstraZeneca serum not to lower their guard and monitor their health.
The European immunizer, also known by the name of Vaxzevria, is one of the vaccines authorized to protect the world population against the effects of Covid-19, for which the health authorities continue to recommend its application, since although there have been cases of two types of thrombosis in immunized people with low platelets, claim that its benefits outweigh its disadvantages.
Read also: EMA describes thrombosis in vaccinated with AstraZeneca as “rare side effects”
However, the EMA has not lost sight of the importance of monitoring the Adverse effects that this vaccine could continue to produce, in few or many people, which is why it has underlined the importance of rapid specialized medical treatment in the face of severe symptoms, reported in the two weeks following inoculation.
Photo: EFE / EPA / NEIL HALL, file
“The probability of this happening is very low, but even so, one must be attentive to the symptoms in order to receive urgent medical treatment that helps recovery and avoid complications,” highlighted members of the Pharmacovigilance Risk Assessment Committee. (PRAC) of the EMA.
“If the signs of blood clots and decrease in platelets and are treated in time, health professionals can help those affected in their recovery and avoid complications “, they detailed.
Read also: AMLO reiterates that the AstraZeneca vaccine will be applied; “It’s safe, there’s no need to fear,” he says
Photo: Raul Arboleda / AFP
Drug marketing specialists urged the population vaccinated with AstraZeneca’s preventive treatment to seek immediate medical assistance for symptoms such as difficulty breathing, chest pain, swelling in the leg, persistent abdominal pain, neurological symptoms such as severe and persistent headaches or blurred vision, and small spots of blood under the skin that extend beyond the injection site.
“It is of great importance that health professionals and people who go to be vaccinated are aware of these risks and are attentive to possible signs or symptoms that usually appear in the first two weeks after vaccination,” explained Sabine Straus, president. of the PRAC and suggested people to contact official care centers in their country, in case they have any questions about the way the vaccine works.